InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Renee PremiumMember
06/30/23 5:48 PM
profile icon
beebob77 Free
11/04/14 7:37 AM
profile icon
stocktrademan Free
08/19/14 10:26 AM

Santhera Pharmaceuticals Holding AG (SPHDF) RSS Feed

Followers
0
Posters
3
Posts (Today)
0
Posts (Total)
3
Created
08/19/14
Type
Free
Moderators
Santhera Pharmaceuticals Holding AG Hammerstrasse 49 Liestal, 4410 Switzerland - Map Phone: 41 61 906 89 50 Fax: 41 61 906 89 51 Website: http://www.santhera.com Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases in the areas of various orphan and niche indications in North America and the EU. The company offers Raxone/Catena for the treatment of Friedreich’s Ataxia. Its products under development include Raxone/Catena, which is in preparation for regulatory re-submission marketing authorization in Europe for Leber's Hereditary Optic Neuropathy, in a Phase III study for Duchenne Muscular Dystrophy, and in a Phase II study for Primary Progressive Multiple Sclerosis; omigapil that is in Phase I pharmacokinetics study in pediatric patients with Congenital Muscular Dystrophy; and Fipamezole, which has completed Phase IIb study for treatment of Dyskinesia in Parkinson's disease. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Liestal, Switzerland.
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
SPHDF Latest News
  • No Recent News Available for this company!
New Post